Raymond James Financial Services Advisors, Inc. Gilead Sciences, Inc. Call Options Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

Call Options

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $1.07 Million - $1.34 Million	18,400 Added 51.54%	54,100 $25,000
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $135,380 - $146,060	2,000 Added 5.93%	35,700 $100,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $387,167 - $423,034	-6,100 Reduced 15.33%	33,700 $98,000
Q1 2018 Apr 16, 2018	BUY	$72.84 - $88.8 $422,472 - $515,040	5,800 Added 17.06%	39,800 $4,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $718,615 - $843,552	10,100 Added 42.26%	34,000 $14,000
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $980,696 - $1.16 Million	13,600 Added 132.04%	23,900 $18,000
Q2 2017 Aug 15, 2017	BUY	N/A	10,300	10,300 $38,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.5 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.99 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.65 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.5 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account